Abstract:Doxorubicin is one of the most largely prescribed antitumor drug for the treatment of breast, liver and colon cancers as well as leukemia, but the cardiotoxicity of this anthracycline derivative limits its clinical use. Although doxorubicin is toxic to both cancer and cardiac cells, there are evidences suggesting that the mechanism of cell death is different for the two cell types. To investigate further this issue, we have compared the proapoptotic effects of doxorubicin and the functionally related anthracenedione compound mitoxantrone, which is also used in the clinic for the treatment of cancer. After evaluating the toxicity of the two drugs to mammary adenocarcinoma MTLn3 cells and H9C2 cardiomyocytes, we dissected the drug-induced apoptotic machinery by measuring the effects on the cell cycle progression, DNA condensation and fragmentation, production of endogenous peroxides and caspase activation. Both doxorubicin and mitoxantrone are potent inducers of apoptosis in H9C2 cardiomyocytes and MTLn3 breast cancer cells, but there are significant differences between the two cell types in terms of kinetics and order of the events. In particular, flow cytometry measurements of drug-induced changes in mitochondrial transmembrane potential and mitochondrial mass with different fluorescent probes suggested that the two drugs induced a progressive increase in mitochondrial mass in the cancer cells but not in the cardiac cells. The hypothesis was validated by means of electron microscopy, which revealed a significant increase in the number of mitochondria in drug-treated MTLn3 but not in H9C2 cells. The mitochondrial proliferation precedes the nuclear apoptosis in doxorubicin-treated MTLn3 cells. The changes in the architecture and number of mitochondria are linked to the drug-induced perturbation of the cell cycle progression and apoptosis. The proliferation of mitochondria could explain the higher toxicity of doxorubicin to cancer cells compared to cardiac cells and this suggests novel therapeutic opportunities to better control the cardiotoxicity of anthracyclines.

Effects of mitoxantrone on the proliferation of MCF-7 cell lines

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

[Effect of Mitoxantrone on Proliferation and Apoptosis of Human Multiple Myeloma Cell RPMI8226].

Effect of 3,6-Dihydroxyflavone on proliferation of MCF-7 cell lines

Effect of Apoptosis Induced by Mitoxantrone on Human Nasopharyngeal Carcinoma Cell Line CNE-2

Effects of isomycin derivant on anti-proliferation and inducing apoptosis of human breast carcinoma cell line MCF-7

Effects of Matrine on the Proliferation and Apoptosis Induction in Human Malignant Melanoma Cell Line A375

The Effects of X-Ray Irradiation on the Proliferation and Apoptosis of Mcf-7 Breast Cancer Cells

Determination of genomic DNA methylation levels in mitoxantrone-resistant breast cancer cell lines by capillary electrophoresis

Effect of Tamoxifen and Megestrol Acetate on Growth and Apoptosis in MCF-7 Breast Cancer Cell Strain in Vitro

Inhibiting Effect of Mitomycin C on Human Nasopharyngeal Carcinoma Cell Line HNE2、HNE2/lmp1 and Its Mechanism

The Effect of Mithramycin A on Proliferation of Human Liver Carcinoma Cell Line Huh-7

THE ANTITUMOR ACTIVITY OF XIMENYNIC ACID ON HCT116 CELLS AND ITS MECHANISM

Effect of xy2004, a centchroman derivative, on proliferation of MCF-7 cells in vitro and the mechanism

Effect of cryptotanshinone on the expression of cell cycle regulatory factors in human breast cancer MCF-7 cells

Effects of xy9902 a centchroman derivative on proliferation of MCF-7 cells

[Effects of Matrine on the Relative Molecules Expression of Proliferation and Apoptosis in K562 Cells].

Effect of Matrine on Inhibiting Proliferation and Inducing Apoptosis of Human Intestinum Crassum Carcinoma HT29 Cells

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells

[Effect of Lycopene on the Proliferation of MCF-7 and MDA-MB-231 Cells].